Cell death-inducing DFFA-like effector B (CIDEB) iRNA compositions and methods of use thereof
US12416006B2 · kind B2 · utility
0Cited by
242References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2024 |
| Grant date | Sep 16, 2025 |
| Priority date | — |
| Expiry date | Oct 28, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/351
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the CIDEB gene, as well as methods of inhibiting expression of CIDEB, and methods of treating subjects that would benefit from reduction in expression of CIDEB, such as subjects having a CIDEB-associated disease, disorder, or condition, using such dsRNA compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.